Canadian Association of Provincial Cancer Agencies logo

The 2024-25 annual report from the Pan-Canadian Cancer Genomics Community of Practice showcases achievements throughout the year and details next steps toward equitable, standardized biomarker testing.

Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.

The Pan-Canadian Cancer Genomics Community of Practice is prioritizing the development of a consensus-based assessment framework to guide adoption and funding decisions for genetic and genomic biomarkers in cancer care.